Clinical Study

Effects of Lamellar Keratectomy and Intrastromal Injection of 0.2% Fluconazole on Fungal Keratitis

Table 2

Clinical characteristics of 8 failed cases.

PatientThe second
surgery
The max diameter
of lesion (mm)
The max depth
of lesion (%)
Fungus
identified
UCVABCVA

1LKT + CF4.0, 4.041.5, 37.3F. solani 20/60,
20/80
20/60,
20/60
2LKT + CF3.5, 3.530.6, 53.7F. solani FC/BE,
20/100
FC/BE,
20/80
3LKT + CF4.0, 4.549.2, 50.0NegativeFC/1.5 m,
20/60
FC/1.5 m,
20/60
4LKT + CF5.0, 5.046.5,49.5Negative20/125,
20/80
20/125,
20/80
5LKT + CF4.5, 5.043.5, 40.5F. solani 20/100,
20/80
20/100,
20/60
6LKP4.0, 5.045.0, 70.0A. versicolor 20/200,
20/160,
20/80
20/200,
20/160,
20/60
7LKP5.0, 5.540.2, 63.0A. flavus 20/200,
20/100,
20/100
20/100,
20/100,
20/80
8PKP4.5, 5.039.4, 92.6A. fumigatus FC/1 m,
20/200,
20/60
FC/1 m,
20/100,
20/40

The clinical features before the first and the second surgery (first, second).
BCVA values are before the first surgery and 90 days after the second surgery and when followed up for 1 year in the keratoplasty cases (first, second).
LKT + CF, lamellar keratectomy and inlay conjunctival flap; LKP, lamellar keratoplasty; PKP, penetrating keratoplasty; FC, finger count; BE, before eye.